Eevia Health Plc received two sales orders totaling 516 kSEK / 46 kEUR for Bilberry juice powder made from side streams of Eevia’s main berry extract production
Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 46 kEUR (516 kSEK) sales order from a Finnish customer for organically certified Bilberry Juice powder.
Eevia received a new order from a Finnish customer for a bilberry juice powder product. The product is Bilberry Juice Powder Organic, which is an unstandardized organically certified bilberry juice powder. The product is made from side streams of Eevia’s extract production. It is one of the first major orders for this product. Eevia has the product in stock.
The Finnish customer is a local contract manufacturer that serves Finnish and European brand holders for dietary supplements. The customer is particularly focused on organically certified natural products. Half of the order of kEUR 23 is confirmed and the other half is a blanket order for delivery later in 2024. The orders are expected to be followed by further repeat orders in the future.
Eevia has worked during 2023 to valorize side stream products, producing pilot products and searching for customers. The potential for new revenue streams from these materials is significant because the volume output of these during production is high. As an example, the production of kEUR 50 worth of berry extract may yield an extra kEUR 35 in side-stream revenues if Eevia can sell these at the prices embedded in these two orders. There are some costs in finalizing (evaporation, drying, packaging) these products, but successful valorization will also improve the absolute margin and total revenue, and possibly also the relative margin, per production batch.
“We are excited to get these orders because it is a promising start to the marketing and sale of our side stream products. It constitutes a welcome upcycling development which will impact our profitability and further our industry-leading sustainability status”, comments Anna-Maija Vanhatalo, Sales Manager at Eevia Health.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
